• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Synta Pharmaceuticals Corp. (SNTA)

    -NGM
    2.80 Down 0.06(2.10%) Dec 19, 4:00PM EST
    |After Hours : 2.80 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (90,192) (62,790) (47,380)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation516  738  1,464  
    Adjustments To Net Income6,030  3,322  3,354  
    Changes In Accounts Receivables -   -  116  
    Changes In Liabilities7,165  4,647  (4,459)
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(930)(52)(395)
    Total Cash Flow From Operating Activities (77,411) (54,135) (47,300)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(769)(505)(690)
    Investments(23,884)(9,438)10,019  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities (24,653) (9,943) 9,329  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock38,735  66,216  27,581  
    Net Borrowings30,307  49,299  9,155  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 69,042   115,515   36,736  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (33,022) 51,437   (1,235)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.